Acute myeloid leukemia (AML) is a hematologic malignancy with significant molecular
heterogeneity. MicroRNAs (miRNAs) play a critical role in AML diagnosis, pathogenesis …

Acute myeloid leukemia is a hematologic malignancy with significant molecular
heterogeneity. MicroRNAs have important biological functions and play critical roles in …

Accurately predicting patient outcomes is essential for optimizing treatment and improving
outcomes in pediatric acute myeloid leukemia (AML). In recent years, microRNAs have …

Pediatric acute myeloid leukemia (AML) is a heterogeneous disease with respect to biology
as well as outcome. In this study, we investigated whether known biological subgroups of …

As a highly heterogeneous disease, acute myeloid leukemia (AML) needs fine risk
stratification to get an optimal outcome of patients. MicroRNAs have florid biological …

Objectives This study aimed to investigate the risk miRNAs (microRNAs) for AML (acute
myeloid leukemia) prognosis and related regulatory mechanisms. Methods MiRNA and …

Purpose Children with acute myeloid leukemia (AML) whose disease is refractory to
standard induction chemotherapy therapy or who experience relapse after initial response …

Acute myeloid leukemia (AML) in children is a complex and heterogeneous disease. The
identification of reliable and stable molecular biomarkers for diagnosis, especially early …

Background Recent reports have indicated that microRNAs (miRNAs) play a critical role in
malignancies, and regulations in the progress of adult leukemia. The role of miRNAs in …

Acute lymphoblastic leukemia (ALL) is the most common childhood cancer, whereas acute
myeloid leukemia (AML) is the most common acute leukemia in adults. In general, ALL has a …